5 Dec 2022
SSHRC SAFE AMR Workshop
On 1-2 December 2022, a kick-off meeting for the SSHRC Partnership Grant took place in Banff, Canada. This new multidisciplinary global governance partnership has come together to address the development of drug-resistant microbes that threaten health, food systems, and the environment. The workshop brought together the main partners of the grant t…
21 Oct 2022
Professor Timo Minssen joins LML as a Research Affiliate
The Centre for Law, Medicine and Life Sciences is delighted to welcome Prof. Timo Minssen (University of Copenhagen) as an Affiliate Member. The position of Affiliate covers researchers beyond the Faculty of Law who represent, participate in, or run, specific projects on behalf of LML.Prof. Minssen is Professor of Law at the University of Copenhage…
10 Oct 2022
Prof. Kathy Liddell co-authors mixed-method study on organizational decision making about Covid-19 asymptomatic testing in workplaces
Workplace health interventions can raise complex ethical issues, for example relating to privacy, equity, and unintended consequences. The UK government and some advisory bodies issued guidance on mass asymptomatic testing for COVID-19 during waves of the pandemic, but few resources have focused specifically on the ethical issues in workplace setti…
7 Oct 2022
Prof. Kathy Liddell Represents LML at International Workshop on Antimicrobial Resistance
From 5 – 6 October 2022, Prof. Kathy Liddell participated in the INAMRSS/CeBIL Copenhagen AMR Workshop: Solutions to AMR from the Social Sciences.This Workshop sought to bring together the international scholarly community – in particular those working in the social sciences – to establish a coherent evidence base to guide national and internationa…
12 Sep 2022
Dr John Liddicoat leads LML empirical study on the repurposing of generic drugs
Commentators claim that drug repositioning (i.e. developing new uses for authorised drugs) significantly slows when generics are authorised and, therefore, law reform is necessary to encourage more R&D.'Repositioning Generic Drugs: Empirical Findings and Policy Implications' empirically examines this claim by analysing records of clinical trials. I…
6 Jul 2022
Prof. Mateo Aboy co-authors patent landscape of quantum technologies
Recent technical breakthroughs underscore the potential of second generation quantum technologies, including quantum simulation, quantum sensing and metrology, quantum computation, and quantum communication. Patenting trends of such technologies are an indicator of the pace of innovation at the invention stage. Empirical studies looking at the real…
27 May 2022
Jinal Dadiya featured in Diversifying the Law: Postgraduates in Profile exhibition
Today, the Faculty of Law’s Equality, Diversity and Inclusivity (EDI) Committee launched its Diversifying the Law: Postgraduates in Profile exhibition. Funded by the University’s Diversity Fund, the aim of the project is to highlight and to encourage reflection on diversity and its relationship to the law—not only as academic subject matter or init…
20 Apr 2022
Dr Claire Fenton-Glynn publishes results of survey on international surrogacy arrangements
From 18 February to 30 April 2021, Cambridge Family Law conducted an online survey to shed light on the domestic and international surrogacy arena – why it is done, how it is done, and the issues that intended parents, surrogates, and governments alike must be aware of.In doing so, the survey sought to understand the experiences of those who had be…
13 Apr 2022
LML patent research team published on European patent protection for medical uses of known products and drug repurposing
Finding new therapeutic uses for existing medicines holds significant potential, since it is often faster to develop a drug for a new use if it is already known to be safe and well tolerated by the human body. Repurposing de-risked compounds with previously known therapeutic effects is also an attractive drug development strategy because it can pot…
13 Apr 2022
Dr Liddicoat to participate in Nordic Intellectual Property Review webinar on patent repurposing for rare diseases
On Monday 25 April 2022, Dr John Liddicoat (LML Senior Research Associate) will participate in Patent Repositioning for rare diseases – too much, too little or just right?, a webinar organised by the Nordic Intellectual Property Review.Ensuring access to treatments for underserved populations is a key priority in both the European Medicines Agency’…
23 Mar 2022
American Journal of Public Health publishes article co-authored by Prof. Kathy Liddell on governing global antimicrobial resistance
The American Journal of Public Health has published an article co-authored by Prof. Kathy Liddell (Director of LML) on governing global antimicrobial resistance.Antimicrobial resistance (AMR) is among the most urgent global health challenges of our time. AMR can develop with each use of an antimicrobial, regardless of the setting. Some microbes hav…
27 Jan 2022
Nature Biotechnology accepts paper from LML on European Patent Protection for Medical Uses of Known Products and Drug Repurposing
Nature Biotechnology has accepted an eighth article from LML’s empirical-based IP research group.Drug repurposing is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indications. Finding new therapeutic uses for existing medicines holds significant potential, since it is of…
19 Jan 2022
Dr Stephanie Palmer and Dr Stevie Martin appointed as General Editors of European Human Rights Law Review
Two members of LML, Dr Stephanie Palmer and Dr Stevie Martin have been appointed (alongside Dr Kirsty Hughes) as the General Editors of the European Human Rights Law Review (EHRLR).The EHRLR is the leading human rights law journal providing unrivalled, cutting-edge coverage of key issues in human rights law. It is at the forefront of serious discus…
14 Jan 2022
Medical Law Review publishes article by LML team on negligent standards of care in diagnosis
Diagnosis lies at the heart of the medical encounter, yet it has received much less attention in legal literature than treatment. Though it is widely assumed that negligent diagnosis claims should be governed by the Bolam test, the article ‘Differentiating Negligent Standards of Care in Diagnosis’ argues that this is not always the case.Co-authore…
13 Jan 2022
Medical Law Review publishes LML article on negligent standards of care in diagnosis
Diagnosis lies at the heart of the medical encounter, yet it has received much less attention in legal literature than treatment. Though it is widely assumed that negligent diagnosis claims should be governed by the Bolam test, ‘Differentiating Negligent Standards of Care in Diagnosis’ argues that this is not always the case.Co-authored by Prof. Ka…
